Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.40 | €236.30 | 71.978% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €125.30 | €140.60 | 12.213% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.46 | €26.01 | 33.640% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.35 | €50.33 | 24.740% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.35 | €184.76 | 22.075% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.40 | €421.61 | 16.017% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €29.20 | €41.81 | 43.199% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €97.74 | - | - |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.56 | €3.70 | 137.028% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €18.21 | - | - |